CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $795
- in 4 filings, $795 under 10b5-1 plans
Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-08 | Fraser Claire Director | Grant or award · Stock Option (right to buy) | +6,500 | 6,500 | ||
| 2025-07-01 | Fraser Claire Director | Grant or award · Stock Option (right to buy) | +6,452 | 6,452 | ||
| 2025-04-10 | Fraser Claire Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-04-04 | Fraser Claire Director | Grant or award · Stock Option (right to buy | +60,000 | 60,000 | ||
| 2023-06-22 | Fraser Claire Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-01-04 | Fraser Claire Director | Grant or award · Stock Option (right to buy) | +48,000 | 48,000 |
Page 1 of 1 · 6 trades